Neurocrine Biosciences (NBIX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $161.62 --0%
Revenue Growth %: +26.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +26.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
